GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Catheterization and Cardiovascular Interventions, Wiley, Vol. 82, No. 7 ( 2013-12), p. 1176-1184
    Abstract: We sought to evaluate the procedural characteristics and clinical outcomes of endovascular repair for iliac artery (IA) in‐stent restenosis (ISR). Background An increasing percentage of patients with complex IA occlusive disease are treated with an endovascular approach, but the outcomes of IA‐ISR have not been well described. Methods We analyzed all endovascular procedures for treatment of IA‐ISR performed at our institution between July 2006–December 2010. The primary outcome was primary patency, defined as 〈 50% stenosis as assessed by clinical examination and duplex ultrasonography (DUS). Results Forty‐one lesions in 24 patients who underwent repeated endovascular intervention for treatment of IA‐ISR. Most lesions were unilateral and involved the common IA (66%). The mean length of ISR was 30.1 ± 14.1 mm with type I (focal) and II (diffuse) ISR occurring with the greatest frequency (34% and 39%, respectively). All patients underwent balloon angioplasty; adjunctive stenting zwas performed in 27 (66%) of the lesions. Type II ISR lesions more frequently required stenting (13/16 lesions, P = 0.02 compared with other patterns of ISR). Procedural success was 100% with a mean gain of 0.13 in the ankle‐brachial index ( P = 0.001). The 6‐ and 12‐month primary patency rates were 96% and 82%, respectively. The 12‐month primary‐assisted patency rate was 90% with clinically driven target lesion revascularization (TLR) in three patients. Conclusions Endovascular treatment of IA‐ISR using an approach of balloon angioplasty followed by selective stenting is associated with high‐patency rates and low rates of TLR at 1 year. © 2013 Wiley Periodicals, Inc.
    Type of Medium: Online Resource
    ISSN: 1522-1946 , 1522-726X
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2013
    detail.hit.zdb_id: 2001555-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Catheterization and Cardiovascular Interventions, Wiley, Vol. 82, No. 7 ( 2013-12), p. 1168-1174
    Abstract: The purpose of this study was to identify the relationship between angiographic patterns of restenosis and outcomes after endovascular treatment of femoro‐popliteal in‐stent restenosis (FP‐ISR). Background ISR is a frequent clinical problem after femoro‐popliteal stenting. Methods This was a single center study of all endovascular interventions for FP‐ISR from 2006 to 2012. Class I ISR was defined as focal lesions ≤50 mm; Class II ISR as lesions  〉  50 mm; and Class III ISR as stent chronic total occlusion. Recurrent ISR was defined as peak systolic velocity ratio  〉  2.4 by duplex ultrasound. Results Among 75 cases of FP‐ISR, 28 (37%) were Class I, 22 (29%) were Class II, and 25 (33%) were Class III. The mean lesion length was 26 mm for Class I, 135 mm for Class II, and 178 mm for Class III ISR. Patients with Class III ISR more frequently had ISR extending into both the superficial femoral and popliteal artery (48% vs. 18%, P  = 0.005). Balloon angioplasty was used most frequently to treat Class I ISR, while adjunctive atherectomy and/or stenting was used for almost all cases of Class III ISR. During 2‐year follow‐up, rates of repeat restenosis were 39% for Class I, 67% for Class II, and 72% for Class III ISR ( P  = 0.04). Rates of stent occlusion were 8% for Class I, 11% for Class II, and 52% for Class III ISR ( P  = 0.009). Class III ISR was associated with significantly increased risk of recurrent ISR (HR 2.4, 95% CI 1.1–5.6) and recurrent occlusion (HR 5.8, 95% CI 1.8–19.0) compared to other types of ISR. Conclusion Angiographic patterns of FP‐ISR are important determinants of subsequent outcomes. Repeat restenosis and occlusion remain common despite currently available technologies.© 2013 Wiley Periodicals, Inc.
    Type of Medium: Online Resource
    ISSN: 1522-1946 , 1522-726X
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2013
    detail.hit.zdb_id: 2001555-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Liver International, Wiley, Vol. 43, No. 5 ( 2023-05), p. 989-999
    Abstract: Alanine aminotransferase (ALT) measurement is essential for evaluation of liver disease. We validated a novel rapid point‐of‐care (POC) test for ALT1 against laboratory ALT. Methods Stored plasma samples from adults with chronic liver disease (Test cohort n  = 240; Validation cohort n  = 491) were analysed using the BioPoint® antigen immunoassay POC ALT1 lateral flow test, which provides quantitative ALT results (Axxin handheld reader) or semi‐quantitative results (visual read, cut off 40 IU/ml). The accuracy of POC ALT1 to detect ALT 〉 40 IU/L was determined by ROC analysis. In patients with chronic hepatitis B, treatment eligibility (EASL criteria) was determined using POC ALT1 and compared to laboratory ALT. Results POC ALT1 test had good accuracy for laboratory ALT 〉 40 IU/L: AUROC 0.93 (95% CI: 0.89–0.96) in the Test cohort and AUROC 0.92 (95% CI: 0.88–0.95) in the Validation cohort. POC ALT1 cut off of 0.8 for ALT 〉 40 IU/L maximised sensitivity (97%) and specificity (71%) in the Test cohort (42% laboratory ALT 〉 40 IU/L) and yielded PPV 84% and NPV 91% in the Validation cohort (19% laboratory ALT 〉 40 IU/L). Semi‐quantitative POC ALT1 had good accuracy for laboratory ALT in the Validation cohort (AUROC 0.85, 95% CI: 0.81–0.99; sensitivity 77% and specificity 93%). Combined with HBV DNA and transient elastography, both quantitative and semi‐quantitative POC ALT1 tests had good accuracy for excluding hepatitis B treatment needs (sensitivity 96%, specificity 78% and NPV 99%). Conclusion The POC ALT1 test had good accuracy for elevated ALT levels and for determining treatment eligibility among people with chronic hepatitis B.
    Type of Medium: Online Resource
    ISSN: 1478-3223 , 1478-3231
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2124684-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Journal of Medical Primatology, Wiley, Vol. 29, No. 3-4 ( 2000-08), p. 182-192
    Abstract: Natural blood‐borne antigen‐presenting cells (APCs) were tested for their ability to augment antigen presentation for SIV vaccines. Fibrocytes and monocyte‐derived dendritic cells (DCs) were isolated from multiple Macaca fascicularis . Macaque fibrocytes displayed the characteristic cellular morphology and stained positive for CD34 and collagen, as observed in human and murine fibrocytes. Macaque DCs were generated from monocytes by culturing in granulocyte–macrophage colony stimulating factor and interleukin‐4 (IL‐4). Two days after maturation, cells were enriched for the DC marker CD83. Fibrocytes and DCs were each transfected with green fluorescence protein expression plasmids or DNA expression vectors encoding all of the SIVmne structural and regulatory genes. Autologous DCs were re‐infused into macaques subcutaneously (sc) following transfection; mixing with recombinant SIV antigens or inactivated whole SIV in vitro ; or mock‐treatment. Autologous monocyte‐derived DCs pulsed with whole inactivated SIV were re‐infused and elicited cellular and/or humoral responses in vivo in eight of ten vaccinated macaques.
    Type of Medium: Online Resource
    ISSN: 0047-2565 , 1600-0684
    Language: English
    Publisher: Wiley
    Publication Date: 2000
    detail.hit.zdb_id: 2026219-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...